新型药物递送系统研发与应用专题 |
|
|
|
|
高分子纳米材料用于口服胰岛素递送体系* |
马品品,熊向源**() |
江西科技师范大学生命科学学院 南昌 330013 |
|
Polymeric Nanomaterials Used in Oral Insulin Delivery Systems |
MA Pin-pin,XIONG Xiang-yuan**() |
College of Life Sciences, Jiangxi Science and Technology Normal University, Nanchang 330013, China |
[1] |
International Diabetes Federation. IDF Diabetes Atlas, 10th ed. [2022-04-21]. https://www.diabetesatlas.org.
|
[2] |
Despins L A, Wakefield B J. Making sense of blood glucose data and self-management in individuals with type 2 diabetes mellitus: a qualitative study. Journal of Clinical Nursing, 2020, 29(13-14): 2572-2588.
doi: 10.1111/jocn.15280
pmid: 32279366
|
[3] |
Suplotova L A, Sudnitsyna A S, Romanova N V. Analysis of the quality of life of patients with type 1 diabetes mellitus in real clinical practice who received insulin degludec. Meditsinskiy Sovet, 2021(14): 96-103.
|
[4] |
Chen G Y, Kang W R, Li W Q, et al. Oral delivery of protein and peptide drugs: from non-specific formulation approaches to intestinal cell targeting strategies. Theranostics, 2022, 12(3): 1419-1439.
doi: 10.7150/thno.61747
pmid: 35154498
|
[5] |
Park H, Otte A, Park K. Evolution of drug delivery systems: from 1950 to 2020 and beyond. Journal of Controlled Release, 2022, 342: 53-65.
doi: 10.1016/j.jconrel.2021.12.030
|
[6] |
Cui Z X, Qin L, Guo S, et al. Design of biotin decorated enterocyte targeting muco-inert nano complexes for enhanced oral insulin delivery. Carbohydrate Polymers, 2021, 261: 117873.
doi: 10.1016/j.carbpol.2021.117873
|
[7] |
Jiang W X, Chen L, Guo X, et al. Combating multidrug resistance and metastasis of breast cancer by endoplasmic reticulum stress and cell-nucleus penetration enhanced immunochemotherapy. Theranostics, 2022, 12(6): 2987-3006.
doi: 10.7150/thno.71693
pmid: 35401832
|
[8] |
Cheng H B, Cui Z X, Guo S, et al. Mucoadhesive versus mucopenetrating nanoparticles for oral delivery of insulin. Acta Biomaterialia, 2021, 135: 506-519.
doi: 10.1016/j.actbio.2021.08.046
pmid: 34487859
|
[9] |
Liu L, Zhang Y, Yu S J, et al. Dual stimuli-responsive nanoparticle-incorporated hydrogels as an oral insulin carrier for intestine-targeted delivery and enhanced paracellular permeation. ACS Biomaterials Science & Engineering, 2018, 4(8): 2889-2902.
|
[10] |
Banerjee A, Ibsen K, Brown T, et al. Ionic liquids for oral insulin delivery. Proceedings of the National Academy of Sciences of the United States of America, 2018, 115(28): 7296-7301.
|
[11] |
Seyam S, Nordin N A, Alfatama M. Recent progress of chitosan and chitosan derivatives-based nanoparticles: pharmaceutical perspectives of oral insulin delivery. Pharmaceuticals (Basel, Switzerland), 2020, 13(10): 307.
|
[12] |
Xu Z Y, Chen L, Duan X Y, et al. Microparticles based on alginate/chitosan/casein three-dimensional system for oral insulin delivery. Polymers for Advanced Technologies, 2021, 32(11): 4352-4361.
doi: 10.1002/pat.v32.11
|
[13] |
Fu Y, Sun Y X, Chen M, et al. Glycopolymer nanoparticles with on-demand glucose-responsive insulin delivery and low-hypoglycemia risks for type 1 diabetic treatment. Biomacromolecules, 2022, 23(3): 1251-1258.
doi: 10.1021/acs.biomac.1c01496
|
[14] |
Zhou Y H, Liu L, Cao Y, et al. A nanocomposite vehicle based on metal-organic framework nanoparticle incorporated biodegradable microspheres for enhanced oral insulin delivery. ACS Applied Materials & Interfaces, 2020, 12(20): 22581-22592.
|
[15] |
Kumari Y, Singh S K, Kumar R, et al. Modified apple polysaccharide capped gold nanoparticles for oral delivery of insulin. International Journal of Biological Macromolecules, 2020, 149: 976-988.
doi: S0141-8130(19)39044-0
pmid: 32018009
|
[16] |
Huang Q, Yu H J, Wang L, et al. Synthesis and testing of polymer grafted mesoporous silica as glucose-responsive insulin release drug delivery systems. European Polymer Journal, 2021, 157: 110651.
doi: 10.1016/j.eurpolymj.2021.110651
|
[17] |
Pauletti G M, Gangwar S, Knipp G T, et al. Structural requirements for intestinal absorption of peptide drugs. Journal of Controlled Release, 1996, 41(1-2): 3-17.
doi: 10.1016/0168-3659(96)01352-1
|
[18] |
Evans D F, Pye G, Bramley R, et al. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut, 1988, 29(8): 1035-1041.
pmid: 3410329
|
[19] |
Saeed S, Irfan M, Naz S, et al. Routes and barriers associated with protein and peptide drug delivery system. JPMA the Journal of the Pakistan Medical Association, 2021, 71(8): 2032-2039.
|
[20] |
Cheng H, Leblond C P. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. III. Entero-endocrine cells. The American Journal of Anatomy, 1974, 141(4): 503-519.
doi: 10.1002/(ISSN)1553-0795
|
[21] |
Sonia T A, Sharma C P. An overview of natural polymers for oral insulin delivery. Drug Discovery Today, 2012, 17(13-14): 784-792.
doi: 10.1016/j.drudis.2012.03.019
pmid: 22521664
|
[22] |
Li S Y, Qin T T, Chen T T, et al. Poly(vinyl alcohol)/poly(hydroxypropyl methacrylate-co-methacrylic acid) as pH-sensitive semi-IPN hydrogels for oral insulin delivery: preparation and characterization. Iranian Polymer Journal, 2021, 30(4): 343-353.
doi: 10.1007/s13726-020-00893-7
|
[23] |
Volpatti L R, Matranga M A, Cortinas A B, et al. Glucose-responsive nanoparticles for rapid and extended self-regulated insulin delivery. ACS Nano, 2020, 14(1): 488-497.
doi: 10.1021/acsnano.9b06395
pmid: 31765558
|
[24] |
Xi Z Y, Ahmad E, Zhang W, et al. Dual-modified nanoparticles overcome sequential absorption barriers for oral insulin delivery. Journal of Controlled Release: Official Journal of the Controlled Release Society, 2022, 342: 1-13.
doi: 10.1016/j.jconrel.2021.11.045
|
[25] |
Xiong X Y, Li Y P, Li Z L, et al. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery. Journal of Controlled Release, 2007, 120(1-2): 11-17.
pmid: 17509718
|
[26] |
Xie S, Gong Y C, Xiong X Y, et al. Targeted folate-conjugated pluronic P85/poly(lactide-co-glycolide) polymersome for the oral delivery of insulin. Nanomedicine (London, England), 2018, 13(19): 2527-2544.
doi: 10.2217/nnm-2017-0372
|
[27] |
Wang A H, Fan W W, Yang T T, et al. Liver-target and glucose-responsive polymersomes toward mimicking endogenous insulin secretion with improved hepatic glucose utilization. Advanced Functional Materials, 2020, 30(13): 1910168.
doi: 10.1002/adfm.v30.13
|
[28] |
Zhou D X, Li S Y, Fei Z X, et al. Glucose and pH dual-responsive polymersomes with multilevel self-regulation of blood glucose for insulin delivery. Biomacromolecules, 2021, 22(9): 3971-3979.
doi: 10.1021/acs.biomac.1c00772
pmid: 34423981
|
[29] |
Lee S W, Kim Y M, Cho C H, et al. An open-label, randomized, parallel, phase II trial to evaluate the efficacy and safety of a cremophor-free polymeric micelle formulation of paclitaxel as first-line treatment for ovarian cancer: a Korean gynecologic oncology group study (KGOG-3021). Cancer Research and Treatment, 2018, 50(1): 195-203.
doi: 10.4143/crt.2016.376
|
[30] |
Li C, Liu X Y, Zhang Y L, et al. Nanochaperones mediated delivery of insulin. Nano Letters, 2020, 20(3): 1755-1765.
doi: 10.1021/acs.nanolett.9b04966
pmid: 32069419
|
[31] |
Han X F, Lu Y, Xie J B, et al. Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions. Nature Nanotechnology, 2020, 15(7): 605-614.
doi: 10.1038/s41565-020-0693-6
pmid: 32483319
|
[32] |
Li C, Wu G, Ma R J, et al. Nitrilotriacetic acid (NTA) and phenylboronic acid (PBA) functionalized nanogels for efficient encapsulation and controlled release of insulin. ACS Biomaterials Science & Engineering, 2018, 4(6): 2007-2017.
|
[33] |
Cao S J, Xu S, Wang H M, et al. Nanoparticles: oral delivery for protein and peptide drugs. AAPS PharmSciTech, 2019, 20(5): 190.
doi: 10.1208/s12249-019-1325-z
|
[34] |
Yan C Y, Gu J W, Lv Y G, et al. Caproyl-modified G2 PAMAM dendrimer (G2-AC) nano complexes increases the pulmonary absorption of insulin. AAPS PharmSciTech, 2019, 20(7): 298.
doi: 10.1208/s12249-019-1505-x
|
[35] |
Parashar A K, Patel P, Gupta A K, et al. Synthesis, characterization and in vivo Evaluation of PEGylated PPI dendrimer for safe and prolonged delivery of insulin. Drug Delivery Letters, 2019, 9(3): 248-263.
doi: 10.2174/2210303109666190401231920
|
[36] |
Bai Y L, Zhou R, Wu L, et al. Nanoparticles with surface features of dendritic oligopeptides as potential oral drug delivery systems. Journal of Materials Chemistry B, 2020, 8(13): 2636-2649.
doi: 10.1039/c9tb02860a
pmid: 32129375
|
[37] |
Dan N, Samanta K, Almoazen H. An update on pharmaceutical strategies for oral delivery of therapeutic peptides and proteins in adults and pediatrics. Children (Basel, Switzerland), 2020, 7(12): 307.
|
[38] |
Bednarikova Z, Antal I, Kubovcikova M, et al. Modified polymer nanospheres:characterization and their anti-amyloid activity to insulin amyloid aggregation. Journal of Magnetism and Magnetic Materials, 2021, 521: 167527.
doi: 10.1016/j.jmmm.2020.167527
|
[39] |
Trinh T A, Le T M D, Ho H G V, et al. A novel injectable pH-temperature sensitive hydrogel containing chitosan-insulin electrosprayed nanosphere composite for an insulin delivery system in type I diabetes treatment. Biomaterials Science, 2020, 8(14): 3830-3843.
doi: 10.1039/d0bm00634c
pmid: 32538381
|
[40] |
Jaradat A, Macedo M H, Sousa F, et al. Prediction of the enhanced insulin absorption across a triple co-cultured intestinal model using mucus penetrating PLGA nanoparticles. International Journal of Pharmaceutics, 2020, 585: 119516.
doi: 10.1016/j.ijpharm.2020.119516
|
[41] |
Fang Y, Wang Q, Lin X J, et al. Gastrointestinal responsive polymeric nanoparticles for oral delivery of insulin: optimized preparation, characterization, and in vivo evaluation. Journal of Pharmaceutical Sciences, 2019, 108(9): 2994-3002.
doi: S0022-3549(19)30253-9
pmid: 31047941
|
[42] |
Gabriel T, Belete A, Hause G, et al. Nanocellulose-based nanogels for sustained drug delivery: preparation, characterization and in vitro evaluation. Journal of Drug Delivery Science and Technology, 2022, 75: 103665.
doi: 10.1016/j.jddst.2022.103665
|
[43] |
Ahmed S, Alhareth K, Mignet N. Advancement in nanogel formulations provides controlled drug release. International Journal of Pharmaceutics, 2020, 584: 119435.
doi: 10.1016/j.ijpharm.2020.119435
|
[44] |
Mudassir J, Darwis Y, Muhamad S, et al. Self-assembled insulin and nanogels polyelectrolyte complex (Ins/NGs-PEC) for oral insulin delivery: characterization, lyophilization and in-vivo evaluation. International Journal of Nanomedicine, 2019, 14: 4895-4909.
doi: 10.2147/IJN
|
[45] |
Elshaarani T, Yu H J, Wang L, et al. Dextran-crosslinked glucose responsive nanogels with a self-regulated insulin release at physiological conditions. European Polymer Journal, 2020, 125: 109505.
doi: 10.1016/j.eurpolymj.2020.109505
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|